NSG 6440 Week 4 APEA Predictor Exam –
Pre-Predictor Test 2025\2026 update
1. A n,15 n,years n,old n,high n,school n,student n,with n,a n,mild n,sore n,throat n,and n,low-grade n,fever
n,that n,has n,persisted n,for n,about n,3 n,weeks. n,She n,reports n,general n,malaise, n,fatigue, n,and n,loss n,of
n,appetite. n,The n,NP n, suspects n, mononucleosis. n, Which n,of n,the n, following n, is n,the n,LEAST
n,appropriate n, intervention?
a. Palpate n,the n,lymph n,nodes n,and n,spleen
b. Examine n,the n,posterior n,oropharynx n,for n,petechiae
c. Obtain n,a n,CBC, n,throat n,culture, n,and n,heterophil n,antibody n,test.
d. Obtain n,an n,urinalyses n,and n,serum n,for n,LFTs n,and n,amylase
Explanation: n,mononucleosis n,is n,a n,symptomatic n,infection n,caused n,by n,the n,Epstein-Bar n,virus.
n,Common n, is n,people n,15-24 n, years n,of n,age. n , Common n,signs n, and n, symptoms n, following
n, incubation n,period n,(1-2 n, months) n, include n, fatigue, n,chills, n, malaise, n,anorexia, n,white n,tonsillar
n,exudates n, and n, lymphadenopathy n,or n,posterior n,cervical n,region. n,Splenomegaly n,can n,be n,present. n,A
n,maculopapular n,or n,occasionally n, a n,petechial n,rash n, occurs n, in n, less n,than n,15% n,of n,patients. n, A
n,diagnosis n, is n,usually n, made n,using n,the n,Monospot. n,In n,addition, n,neutropenia n,and n,lymphocytosis
n,are n,usually n,detected n,in n,the n,CBC.
2. A n,32 n,years n,old n,male n,patient n,complaint n,of n,urinary n,frequency n,and n,burning n,on n,urination
n,for n,3 n,days. n,Urinalyses n,reveals n, bacteriuria n,and n,positive n,nitrites. n,He n,denies n,any n,past n,hx. n,Of
n,urinary n,tract n,infections. n,The n, initial n,treatment n,should n, be:
a. trimethoprim-sulfamethoxazole n,(Bactrim, n,Sulfatrim) n,for n,7-10 n,day
b. ciprofloxacin n,(Cipro) n,for n,3-5 n,days
c. Trimethoprim-Sulfamethoxazole n,for n,3 n,days
d. 750 n,mg n,ciprofloxacin n,as n,a n,one-time n,dose
Explanation: n,trimethoprim-sulfamethoxazole n,(TMPS) n,is n,usually n,n n,appropriate n,medication n,to
n,treat n,urinary n,tract n, infections n, in n, most n,patients. n , In n,the n, case n,of n,community n,resistance n,to
n,TMPS
>20%^, n,another n,medication n,should n,be n,substituted. n,In n,men, n,the n,appropriate n,length n,of n,time n,is
n,7-10 n,days. n, Women n, may n, be n,treated n,for n,3 n,days n, for n,uncomplicated n,UTI
3. Which n,agent n,is n,most n,effective n,for n,the n,treatment n,of n,nodulocystic n,acne?
a. Benzoyl n,peroxide n,(Benzac)
b. Retinoic n,acid n,(Retinn,A)
c. Topical n,tetracycline
d. Isotretinoin)
Explanation: n,Isotretinoin n,(Accutane) n,is n,a n,systemic n,agent n,indicated n,for n,treatment n,with
n,severe n, inflammatory n,acne. n,Guidelines n, for n,its n,use n,must n,be n,clearly n,understood n,by n,the n,patient.
n,A n,woman n,of n,childbearing n,age n, must n,use n,an n,effective n, method n,of n,contraception n, because
n, isotretinoin n, is n,teratogenic. n,There n,are n,many n,restrictions n,in n,prescribing n,this n,medication n,because
n,of n,the n,teratogenic n, effects n, is n,given n,during n,pregnancy. n,Therefore, n, it n, is n,a n,pregnancy n,category
1
, X.
n,
4. An n,18 n,y/o n,woman n,is n,taking n,a n,combined n,hormonal n,oral n,contraceptive. n,She n,should n,be
2
,instructed n,to n,use n,a n,backup n,method n,for n,the n,prevention n,of n,pregnancy
a. Throughout n,the n,week n,of n,placebo n,pills
b. If n,prescribed n,topiramate n,(Topamax) n,for n,the n,treatment n,of n,migraines.
3
, c. If n,prescribed n,amoxicillin/clavulanate n,(Augmentin) n,for n,a n,sinus n,infection
d. if n,she n,forgets n,to n,take n,a n,single n,dose n,of n,the n,contraceptive
Explanation: n,Anticonvulsant n,including n,phenytoin n,(Dilantin), n,carbamazepine n,(Tegretol),
n,primidone n,(Mysoline), n,topiramate n,(Topamax) n,and n,oxcarbazepine n,(Trileptal) n,reduce n,the
n,effectiveness n,of n,contraceptives. n,Depo-medroxyprogesterone n,acetate n , injections n,or
n,levonorgestrel- n,releasing n, intrauterine n,devices n,would n, be n,a n, better n,method n,of n,contraceptive n, for
n,patients n,taking n,anticonvulsants. n, Most n,commonly n,used n,antibiotics n, have n, not n,been n,proven n,to
n,reduce n,the n,effectiveness n,of n,contraceptives. n,Rifampin n, is n,an n,exception, n, and n, additional n,…. n,Be
n,used n, by n,women n,taking n,this n,drug n,and n,using n,oral n,contraceptives, n,transdermal, n,or n,vaginal
n,ring n,preparations.
Additional n,backup n,contraception n,should n,be n,used n,if n,taking n,antifungal n,agents. n,No n,additional
n,protection n,is n,needed n,thought n,the n,week n,of n,placebo n,pills. n,Missing n,one n,single n,dose n,of
n,contraceptive n,does n, not n,require n,additional n,protection, n, missing n, more n,than n,one n,doses n,does.
5. A n,44 n,years n,old n,female n,patient n,has n,diabetes. n,Her n,total n,cholesterol n,(TC) n,is n,250 n,mg/dl
n,(6.5 n, mmol/L), n,LDL= n,190 n, mg/dL n,(4.94 n, mmol/L), n,HDL= n,25 n, mg/dL n,(65 n, mmol/L), n,and
n,triglycerides= n,344 n,mg/dL n,(8.94 n,mmol/L). n,What n,agent n,have n,the n,greatest n,effect n,on n,improving
n,her n,lipid n,profile n,and n,reducing n, morbidity n,and n, mortality n,associates n,with n,dyslipidemia?
a. Niacin n,(Niaspan)
b. Atorvastatin
c. Omega n,3 n,fatty n,acids
d. Fenofibrates
Explanation: n,First n,and n,foremost, n,it n,is n,essential n,to n,educate n,individuals n,on n,a n,heart-healthy
n, lifestyle. n,LDL-C n,is n,one n,of n,the n,major n,culprits n,in n,the n,development n,of n,atherosclerotic n,heart
n,disease. n,The n,target n, level n,of n,LDL-C n, is n, between n, 50 n,to n,70mg/dl n,to n,prevent n,plaque n, formation
n, in n,the n, blood n, vessels. n,Guidelines n, strongly n,recommend n,statin n,therapy n, because n,they n,primarily
n, lower n, LDL-C n, levels, n, but n,they n,also n, have n,the n, secondary n,effects n,of n, lowering n,triglyceride n,and
n, increasing n,HDL-C n, levels.
6. A n,30 n,years n,old n,female n,comes n,into n,a n,clinic n,with n,classic n,signs n,and n,symptoms n,of
n,appendicitis. n,The n,NP n, fails n,to n,refer n,the n,patient n,to n,a n,surgeon. n,The n,appendix n,ruptures n,and
n,the n,woman n,die. n,This n, is n,an n,example n,of
a. Failure n,of n,diligence
b. Professional n,liability
c. Negligence
d. Malpractice
Explanation: n,malpractice, n,a n,negligence n,tort, n,occurs n,when n,a n,health n,care n,professional’s n,actions
n,fall n, bellow n,the n, appropriate n,standard n,of n, care n,and n, hurts n,the n,patient. n,In n,this n,case n,the n,patient
n,came n,with n,sings n,and n, symptoms n, indicating n, appendicitis n,and n,the n,NP n, failed n,to n,refer n,the
n,patient..
7. A n,NP n,has n,recently n,been n,hired n,to n,work n,in n,a n,fast n,track n,facility. n,The n,NP n,employer
n,asked n,if n, she n, has n, “a n,problem n,prescribing n, medications n, for n,emergency n,contraception.”
n,The n,NP n,replies n,affirmatively. n,This n, is:
a. Grounds n,for n,dismissal
4
Pre-Predictor Test 2025\2026 update
1. A n,15 n,years n,old n,high n,school n,student n,with n,a n,mild n,sore n,throat n,and n,low-grade n,fever
n,that n,has n,persisted n,for n,about n,3 n,weeks. n,She n,reports n,general n,malaise, n,fatigue, n,and n,loss n,of
n,appetite. n,The n,NP n, suspects n, mononucleosis. n, Which n,of n,the n, following n, is n,the n,LEAST
n,appropriate n, intervention?
a. Palpate n,the n,lymph n,nodes n,and n,spleen
b. Examine n,the n,posterior n,oropharynx n,for n,petechiae
c. Obtain n,a n,CBC, n,throat n,culture, n,and n,heterophil n,antibody n,test.
d. Obtain n,an n,urinalyses n,and n,serum n,for n,LFTs n,and n,amylase
Explanation: n,mononucleosis n,is n,a n,symptomatic n,infection n,caused n,by n,the n,Epstein-Bar n,virus.
n,Common n, is n,people n,15-24 n, years n,of n,age. n , Common n,signs n, and n, symptoms n, following
n, incubation n,period n,(1-2 n, months) n, include n, fatigue, n,chills, n, malaise, n,anorexia, n,white n,tonsillar
n,exudates n, and n, lymphadenopathy n,or n,posterior n,cervical n,region. n,Splenomegaly n,can n,be n,present. n,A
n,maculopapular n,or n,occasionally n, a n,petechial n,rash n, occurs n, in n, less n,than n,15% n,of n,patients. n, A
n,diagnosis n, is n,usually n, made n,using n,the n,Monospot. n,In n,addition, n,neutropenia n,and n,lymphocytosis
n,are n,usually n,detected n,in n,the n,CBC.
2. A n,32 n,years n,old n,male n,patient n,complaint n,of n,urinary n,frequency n,and n,burning n,on n,urination
n,for n,3 n,days. n,Urinalyses n,reveals n, bacteriuria n,and n,positive n,nitrites. n,He n,denies n,any n,past n,hx. n,Of
n,urinary n,tract n,infections. n,The n, initial n,treatment n,should n, be:
a. trimethoprim-sulfamethoxazole n,(Bactrim, n,Sulfatrim) n,for n,7-10 n,day
b. ciprofloxacin n,(Cipro) n,for n,3-5 n,days
c. Trimethoprim-Sulfamethoxazole n,for n,3 n,days
d. 750 n,mg n,ciprofloxacin n,as n,a n,one-time n,dose
Explanation: n,trimethoprim-sulfamethoxazole n,(TMPS) n,is n,usually n,n n,appropriate n,medication n,to
n,treat n,urinary n,tract n, infections n, in n, most n,patients. n , In n,the n, case n,of n,community n,resistance n,to
n,TMPS
>20%^, n,another n,medication n,should n,be n,substituted. n,In n,men, n,the n,appropriate n,length n,of n,time n,is
n,7-10 n,days. n, Women n, may n, be n,treated n,for n,3 n,days n, for n,uncomplicated n,UTI
3. Which n,agent n,is n,most n,effective n,for n,the n,treatment n,of n,nodulocystic n,acne?
a. Benzoyl n,peroxide n,(Benzac)
b. Retinoic n,acid n,(Retinn,A)
c. Topical n,tetracycline
d. Isotretinoin)
Explanation: n,Isotretinoin n,(Accutane) n,is n,a n,systemic n,agent n,indicated n,for n,treatment n,with
n,severe n, inflammatory n,acne. n,Guidelines n, for n,its n,use n,must n,be n,clearly n,understood n,by n,the n,patient.
n,A n,woman n,of n,childbearing n,age n, must n,use n,an n,effective n, method n,of n,contraception n, because
n, isotretinoin n, is n,teratogenic. n,There n,are n,many n,restrictions n,in n,prescribing n,this n,medication n,because
n,of n,the n,teratogenic n, effects n, is n,given n,during n,pregnancy. n,Therefore, n, it n, is n,a n,pregnancy n,category
1
, X.
n,
4. An n,18 n,y/o n,woman n,is n,taking n,a n,combined n,hormonal n,oral n,contraceptive. n,She n,should n,be
2
,instructed n,to n,use n,a n,backup n,method n,for n,the n,prevention n,of n,pregnancy
a. Throughout n,the n,week n,of n,placebo n,pills
b. If n,prescribed n,topiramate n,(Topamax) n,for n,the n,treatment n,of n,migraines.
3
, c. If n,prescribed n,amoxicillin/clavulanate n,(Augmentin) n,for n,a n,sinus n,infection
d. if n,she n,forgets n,to n,take n,a n,single n,dose n,of n,the n,contraceptive
Explanation: n,Anticonvulsant n,including n,phenytoin n,(Dilantin), n,carbamazepine n,(Tegretol),
n,primidone n,(Mysoline), n,topiramate n,(Topamax) n,and n,oxcarbazepine n,(Trileptal) n,reduce n,the
n,effectiveness n,of n,contraceptives. n,Depo-medroxyprogesterone n,acetate n , injections n,or
n,levonorgestrel- n,releasing n, intrauterine n,devices n,would n, be n,a n, better n,method n,of n,contraceptive n, for
n,patients n,taking n,anticonvulsants. n, Most n,commonly n,used n,antibiotics n, have n, not n,been n,proven n,to
n,reduce n,the n,effectiveness n,of n,contraceptives. n,Rifampin n, is n,an n,exception, n, and n, additional n,…. n,Be
n,used n, by n,women n,taking n,this n,drug n,and n,using n,oral n,contraceptives, n,transdermal, n,or n,vaginal
n,ring n,preparations.
Additional n,backup n,contraception n,should n,be n,used n,if n,taking n,antifungal n,agents. n,No n,additional
n,protection n,is n,needed n,thought n,the n,week n,of n,placebo n,pills. n,Missing n,one n,single n,dose n,of
n,contraceptive n,does n, not n,require n,additional n,protection, n, missing n, more n,than n,one n,doses n,does.
5. A n,44 n,years n,old n,female n,patient n,has n,diabetes. n,Her n,total n,cholesterol n,(TC) n,is n,250 n,mg/dl
n,(6.5 n, mmol/L), n,LDL= n,190 n, mg/dL n,(4.94 n, mmol/L), n,HDL= n,25 n, mg/dL n,(65 n, mmol/L), n,and
n,triglycerides= n,344 n,mg/dL n,(8.94 n,mmol/L). n,What n,agent n,have n,the n,greatest n,effect n,on n,improving
n,her n,lipid n,profile n,and n,reducing n, morbidity n,and n, mortality n,associates n,with n,dyslipidemia?
a. Niacin n,(Niaspan)
b. Atorvastatin
c. Omega n,3 n,fatty n,acids
d. Fenofibrates
Explanation: n,First n,and n,foremost, n,it n,is n,essential n,to n,educate n,individuals n,on n,a n,heart-healthy
n, lifestyle. n,LDL-C n,is n,one n,of n,the n,major n,culprits n,in n,the n,development n,of n,atherosclerotic n,heart
n,disease. n,The n,target n, level n,of n,LDL-C n, is n, between n, 50 n,to n,70mg/dl n,to n,prevent n,plaque n, formation
n, in n,the n, blood n, vessels. n,Guidelines n, strongly n,recommend n,statin n,therapy n, because n,they n,primarily
n, lower n, LDL-C n, levels, n, but n,they n,also n, have n,the n, secondary n,effects n,of n, lowering n,triglyceride n,and
n, increasing n,HDL-C n, levels.
6. A n,30 n,years n,old n,female n,comes n,into n,a n,clinic n,with n,classic n,signs n,and n,symptoms n,of
n,appendicitis. n,The n,NP n, fails n,to n,refer n,the n,patient n,to n,a n,surgeon. n,The n,appendix n,ruptures n,and
n,the n,woman n,die. n,This n, is n,an n,example n,of
a. Failure n,of n,diligence
b. Professional n,liability
c. Negligence
d. Malpractice
Explanation: n,malpractice, n,a n,negligence n,tort, n,occurs n,when n,a n,health n,care n,professional’s n,actions
n,fall n, bellow n,the n, appropriate n,standard n,of n, care n,and n, hurts n,the n,patient. n,In n,this n,case n,the n,patient
n,came n,with n,sings n,and n, symptoms n, indicating n, appendicitis n,and n,the n,NP n, failed n,to n,refer n,the
n,patient..
7. A n,NP n,has n,recently n,been n,hired n,to n,work n,in n,a n,fast n,track n,facility. n,The n,NP n,employer
n,asked n,if n, she n, has n, “a n,problem n,prescribing n, medications n, for n,emergency n,contraception.”
n,The n,NP n,replies n,affirmatively. n,This n, is:
a. Grounds n,for n,dismissal
4
